Jason Fredette | Senior Vice President, Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Arvin Yang | Senior Vice President and Chief Medical Officer |
Brian DeSchuytner | Senior Vice President and Chief Financial Office |
Jonathan Chang | SVB Securities |
Colleen Kusy | Baird |
Kaveri Pohlman | BTIG |
David Nierengarten | Wedbush |
Boris Peaker | Cowen & Co |
Good morning, and welcome to Mersana Therapeutics Third Quarter 2022 Conference Call and webcast. Currently, all participants are in a listen-only mode. There will be a question answer session at the end of this call. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed.